Valuation (22%) |
Company | Industry |
---|---|---|
P/E Ratio (TTM) | -0.93 | 40.66 |
PEG Ratio (TTM) | 0.01 | 5.42 |
P/S Ratio (TTM) | 47.26 | 6.33 |
P/B Ratio (TTM) | 3.72 | 5.87 |
P/FCF Ratio (TTM) | -1.82 | 37.81 |
Price to 5YR AVG Earnings Ratio | N/A | 59.41 |
Price to 5YR AVG FCF Ratio | N/A | 36.98 |
Profitability (0%) |
Company | Industry |
---|---|---|
ROA (TTM) | -345.69% | 4.66% |
ROE (TTM) | -213.55% | 25.49% |
Net Profit Margin (TTM) | -3,598.50% | 7.22% |
ROIC 5YR AVG | N/A | 6.54% |
Growth (27%) |
4QTR AVG | 3YR AVG | 5YR AVG |
---|---|---|---|
EPS | -43.88% | 7.59% | N/A |
Revenue | 42.56% | 264.55% | N/A |
Net Income | -42.51% | 7.49% | N/A |
Cash Flow | -17.12% | -52.59% | N/A |
Health (32%) |
Company | Industry |
---|---|---|
Current Ratio (TTM) | 5.57 | 2.64 |
Quick Ratio (TTM) | 4.89 | 1.97 |
D/E Ratio (TTM) | N/A | 0.55 |
Interest Coverage (TTM) | -257.98 | 2.38 |
Piotroski F-Score | 3 | 6 |
Altman Z-Score | N/A | 7.18 |
LTL to 5YR AVG FCF | N/A | 3.69 |
Shares Outstanding Growth 5YR AVG | N/A | 1.65% |